Feature Channels:

Vaccines

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

drug, Drug Abuse, drug abuse treatment, Drug Abuse Trends, Bath Salts, Vaccine, Addiction, Substance Abuse

New Vaccine Could Help People Overcome Bath Salts Abuse

Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones, or bath salts. The vaccine blunts the illegal stimulant’s effects on the brain, which could help recovering drug users who experience a relapse.

Medicine

Science

Channels:

Immunity, Immunology, Vaccine

Your Immune System Holds the Line Against Repeat Invaders, Thanks to This Molecule

Pipkin_group_shot.jpg

This new insight may allow researchers to design drugs that improve immune responses to vaccines.

Medicine

Channels:

Vaccines, Vaccination, HPV, HPV and cancer, HPV and children, HPV vaccination, Health, Education, Arizona

They Really Just Don't Understand: Parents More Likely to Agree to HPV Vaccine After Education Intervention

180404 HPV Awareness-7 (1).jpg

ASU intervention study shows promising results for HPV-vaccination education program for parents

Medicine

Science

Channels:

heart vaccine, Atheriosclerosis, Tregs

LJI Researchers Are One Step Closer to an Effective Anti-Atherosclerosis Vaccine

Ley_Circulation.png

A new paper published in Circulation by researchers at La Jolla Institute for Allergy and Immunology reports successful vaccination of atherosclerotic mice with a small chunk of protein snipped out of "bad cholesterol." Vaccination reduced plaque levels in test mice, and other experiments with human blood samples identified the class of T cells likely responsible for positive outcomes. The paper suggests that a comparable strategy could form the basis of a human vaccine.

Medicine

Channels:

Ovarian Cancer, Cancer Vaccine, Pesonalized Medicine

Ludwig Researchers Devise and Test Pioneering Personalized Cancer Vaccine for Ovarian Cancer

LanaAlexGeorge.png

A Ludwig Cancer Research study has shown that an entirely new type of personalized cancer vaccine induces novel, potent and clinically effective immune responses in patients receiving a combination of standard therapies for recurrent, stage III and IV ovarian cancer.

Medicine

Channels:

Ovarian Cancer, personalised medicine, personalized medicine, Clinical Trials, Clinical Trials For Cancer, abramson cancer center, Penn Medicine, Perelman School of Medicine at the University of Pennsylvania, T-cell engineering

Personalized Tumor Vaccine Shows Promise in Pilot Trial

A new type of cancer vaccine has yielded promising results in an initial clinical trial. The personalized vaccine is made from patients’ own immune cells, which are exposed to the contents of the patients’ tumor cells, and then injected into the patients to initiate a wider immune response. The trial, conducted in advanced ovarian cancer patients, was a pilot trial aimed primarily at determining safety and feasibility, but there were clear signs that it could be effective: About half of the vaccinated patients showed signs of anti-tumor T-cell responses, and those “responders” tended to live much longer without tumor progression than those who didn’t respond. The study is published today in Science Translational Medicine.

Science

Channels:

flu, Influenza, Vaccines, Vaccination, Antiviral Drugs, CRISPR, Microbiology

Genetic Screening Tool Identifies How the Flu Infiltrates Cells

influenza-virus-nolabels.jpg

Researchers at the University of Chicago have developed a genetic screening tool that identified two key factors that allow the influenza virus to infect human lung cells. The technique uses new gene editing tools to create a library of modified cells, each missing a different gene, allowing scientists to see which changes impact their response to flu. This in turn could identify potential targets for antiviral drugs.

Medicine

Channels:

Influenza, Influenca vaccine, Neuraminidase, Hemagglutinin, Viral-surface glycoproteins , Viral cellular egress, Shifting focus to neuraminidase, Vaccine effectiveness, Neutralize neuraminidase, Antibodies

For a Better Influenza Vaccine, Focus on the Neglected “N”

Theinfluenzavirussurfacewherethebluetetramersaretheneuraminidaseglycoproteinandthebrowntrimersarethehemagglutininglycoprotein.png

In the April 5, 2018 issue of the journal Cell, researchers push for greater emphasis on the neglected viral-surface influenza protein neuraminidase. For decades, flu vaccines have concentrated on hemagglutinin. The authors maintain that a focus on neuraminidase could lower infection rates and lessen severity.

Medicine

Science

Channels:

Influenza, Immunology, Vaccine, flu, Flu Shot

Scripps Research Discovery Paves Way for Better Flu Prevention, Treatment

Scientists at The Scripps Research Institute have discovered a new aspect of the flu virus and how it interacts with antibodies in the lungs.

Medicine

Channels:

Pertussis, Whooping Cough, Vaccine

Study Explains Resurgence of Pertussis

A team of researchers including scientists from the University of Georgia has found that the resurgence of pertussis, more commonly known as whooping cough, in the U.S. is a predictable consequence of incomplete coverage with a highly effective vaccine. This finding goes against pervasive theories on why we are seeing a steady increase in the disease even though the vaccine is given at an early age.







Chat now!